Conforma

San Diego, United States Founded: 1999 • Age: 27 yrs Acquired By Biogen
Cancer drugs targeting HSP90 molecular chaperones are developed.
Annual revenue - Latest available
Total funding $56.0M 3 rounds
Employees - Tracked headcount
Investors 10 Known backers
Products - Services tracked
Competitors 6 Brand Intelligence

About Conforma

Conforma is a company based in San Diego (United States) founded in 1999 was acquired by Biogen in May 2006. Conforma has raised $56 million across 3 funding rounds from investors including Biogen, Lombard Odier and Domain Associates. Conforma operates in a competitive market with competitors including TrueLens, Black Pearl Vision, Art Optical Contact Lens, Eiyan Lens and Lentes Beautiful Eyes, among others.

  • Headquarter San Diego, United States
  • Sectors
    Consumer
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
Operational Areas
Consumer → Beauty, Personal & Household Care Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Total Equity Funding
    $56 M (USD)

    in 3 rounds

  • Latest Funding Round
    $11 M (USD), Series C

    May 02, 2005

  • Investors
    Biogen

    & 9 more

  • Employee Count
    Not available
  • Acquired by
    Biogen

    (May 02, 2006)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of Conforma

Conforma has successfully raised a total of $56M across 3 strategic funding rounds. The most recent funding activity was a Series C round of $11 million completed in May 2005. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

Investors in Conforma

Conforma has secured backing from 10 investors, including venture fund and institutional investors. Prominent investors backing the company include Biogen, Lombard Odier and Domain Associates.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
Life science & tech focused VC firm investing in the US
Locked Locked Locked
Life Sciences focused VC firm that does early stage investments in the US
Locked Locked Locked
Early-stage life sciences investments are targeted in the healthcare sector.
Locked Locked Locked
Premium access

Investor details for Conforma

Investor domains, locations, round participation, and complete history require an active premium plan.

  • Investor domains
  • Investor locations
  • Funding rounds
  • Participation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Conforma

Investments
Premium access

Investment portfolio details for Conforma

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Conforma

Premium access

Detailed financials for Conforma

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Conforma Comparisons

Conforma Primary company
Description
Cancer drugs targeting HSP90 molecular chaperones are develo...
Location
San Diego, United States
Founded Year
1999
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
Not available
Premium access

Peer comparison for Conforma

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Conforma

Conforma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as TrueLens, Black Pearl Vision, Art Optical Contact Lens, Eiyan Lens and Lentes Beautiful Eyes, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Social insights are integrated with CRM data for customer profiling.
Locked Locked Locked
Contact lenses are branded and distributed by Black Pearl Vision.
Locked Locked Locked
Specializes in designing, producing, and consulting on custom contact lenses for eye conditions.
Locked Locked Locked
Operates a direct-to-consumer brand offering contact lenses on a subscription basis.
Locked Locked Locked
Online store offering cosmetic lenses and eye care kits for consumers.
Premium access

Detailed competitors of Conforma

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Conforma

Premium access

Complete news archive for Conforma

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Conforma

Conforma was founded in 1999 and raised its 1st funding round 2 years after it was founded.

Conforma is headquartered in San Diego, United States. It is registered at San Diego, California, United States.

Lawrence Fritz is the current CEO of Conforma.

Conforma is a funded company, having raised a total of $56M across 3 funding rounds to date.

Conforma Therapeutics was founded in 1999 in San Diego, United States, and operates in the biotechnology sector. Focus is placed on the design and development of pharmaceutical products aimed at treating cancer. Operations center on drugs that target the HSP90 family of molecular chaperones, which regulate tumor cell growth and survival. The company is led by CEO and President Lawrence Fritz.

Conforma's top competitors include TrueLens, Black Pearl Vision and Art Optical Contact Lens.

Conforma has 10 investors. Key investors include Biogen, Lombard Odier, Domain Associates, Forward Ventures, and Lilly Ventures.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available